NEWMarkets

Ani Pharmaceuticals (ANIP) CFO sell $207,480 in stock

Published on 9/1/2026

#ANIP#InsiderTrading#Stocks#CFO
Ani Pharmaceuticals (ANIP) CFO sell $207,480 in stock

AI Summary

Summarized by AI from the source below

Stephen Carey, Senior Vice President and Chief Financial Officer of Ani Pharmaceuticals (ANIP), sold $207,480 worth of company stock. This transaction reflects a significant movement by an executive within the company. Such insider trading can often provide insights into company outlook and may influence investor perception. Monitoring such sales is important for investors as they can impact market sentiment around Ani Pharmaceuticals.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Xeris Biopharma COO Kevin McCulloch Sells $127,308 in Stock
Earnings

Xeris Biopharma COO Kevin McCulloch Sells $127,308 in Stock

Sep 1

Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares
Markets

Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares

Sep 1

Xeris Biopharma (XERS) Beth Hecht Sells $141,434 in Stock
Markets

Xeris Biopharma (XERS) Beth Hecht Sells $141,434 in Stock

Sep 1

Crexendo (CXDO) CTO David Wang Sells $162,500 in Company Stock
Markets

Crexendo (CXDO) CTO David Wang Sells $162,500 in Company Stock

Sep 1